Related Experiment Videos
Familial infantile myasthenia gravis: a preventable cause of sudden death
Southern Medical Journal
|February 1, 1985
Insights
Familial infantile myasthenia gravis, a rare syndrome in infants of nonmyasthenic mothers, presents with recurrent apnea and respiratory depression. Early diagnosis and treatment are crucial to prevent sudden death in affected infants.
Area of Science:
- Pediatric Neurology
- Genetics
- Rare Diseases
Background:
- Familial infantile myasthenia gravis (FIMG) is an exceptionally rare neuromuscular disorder.
- It affects infants born to mothers without myasthenia gravis, suggesting a distinct genetic etiology.
Observation:
- The described infant presented with recurrent apnea and significant respiratory depression.
- Notably, ophthalmoplegia (paralysis of eye muscles) was absent in this case.
Findings:
- This case highlights the characteristic clinical features of FIMG, including severe respiratory compromise.
- The absence of ophthalmoplegia differentiates it from some other congenital myasthenic syndromes.
Implications:
- Untreated FIMG carries a high risk of mortality, often due to respiratory failure and sudden death.
- Recognition of these specific symptoms is vital for prompt diagnosis and intervention in at-risk infants.
- Further research into the genetic underpinnings of FIMG is warranted to develop targeted therapies.
Abstract:
We have described an infant with familial infantile myasthenia gravis, the rarest of the myasthenic syndromes, which occurs in infants of nonmyasthenic mothers. Recurrent apnea and respiratory depression with an absence of ophthalmoplegia are features of this syndrome, which if untreated can lead to sudden death.